NCT02053324View on ClinicalTrials.gov

AvidinOX + [177Lu]DOTA-biotin (or 177Lu-ST2210) Complex in Patients With Liver Metastases From Colorectal Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 11, 2013

Primary Completion Date

June 1, 2019

Study Completion Date

July 1, 2019

Conditions
Liver Metastases
Interventions
COMBINATION_PRODUCT

AvidinOX/ST2210

One intralesion injection of AvidinOX followed by an intravenous infusion of ST2210

Trial Locations (4)

1090

Allgemeines Krankenhaus Wien, Vienna

30174

Ospedale dell' Angelo di Mestre, Mestre

04100

Ospedale S. Maria Goretti, Latina

00189

S. Andrea Hospital, Rome

Sponsors

Lead Sponsor

Alfasigma S.p.A.
All Listed Sponsors
lead

Alfasigma S.p.A.

INDUSTRY